Back to Authors

Cole, Gregory M.

0000-0002-6848-7455

A5108668809 | I161318765

Mayo Clinic

University of California, Los Angeles

Citations 3

In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils

ACS Chemical Neuroscience | January 5, 2026 | Volume: 17 | Issue: 2 | Pages: 450-464

10.1021/acschemneuro.5c00940 | PMID 41486697

Biochemical markers in persons with preclinical familial Alzheimer disease

Neurology | May 29, 2008 | Volume: 71 | Issue: 2 | Pages: 85-92

10.1212/01.wnl.0000303973.71803.81 | PMID 18509095

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Science | July 27, 2002 | Volume: 274 | Issue: 5284 | Pages: 99-103

10.1126/science.274.5284.99 | PMID 8810256

Transgenic mice overexpressing the 695-amino acid isoform of human Alzheimer β-amyloid (Aβ) precursor protein containing a Lys 670 → Asn, Met 671 → Leu mutation had normal learning and memory in spatial reference and alternation tasks at 3 months of age but showed impairment by 9 to 10 months of age. A fivefold increase in Aβ(1-40) and a 14-fold increase in Aβ(1-42/43) accompanied the appearance of these behavioral deficits. Numerous Aβ plaques that stained with Congo red dye were present in cortical and limbic structures of mice with elevated amounts of Aβ. The correlative appearance of behavioral, biochemical, and pathological abnormalities reminiscent of Alzheimer's disease in these transgenic mice suggests new opportunities for exploring the pathophysiology and neurobiology of this disease.